WuXi PharmaTech (Cayman) Inc. (WX)
-NYSE 20.43 
0.11(0.54%) May 17, 4:01PM EDT
| Prev Close: | 20.32 |
|---|
| Open: | 20.21 |
|---|
| Bid: | 18.58 x 100 |
|---|
| Ask: | 20.85 x 100 |
|---|
| 1y Target Est: | 22.47 |
|---|
| Beta: | 0.9 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 20.08 - 20.48 |
|---|
| 52wk Range: | 13.00 - 21.14 |
|---|
| Volume: | 361,020 |
|---|
| Avg Vol (3m): | 342,908 |
|---|
| Market Cap: | 1.44B |
|---|
| P/E (ttm): | 17.03 |
|---|
| EPS (ttm): | 1.20 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- WuXi PharmaTech Beats on Both Top and Bottom Linesat Motley Fool(Wed, May 15)
- Analysts: Market Is Beginning to Recognize Tesla and 3 Other Research Notes to Check Outat Wall St. Cheat Sheet(Tue, May 14)
- WuXi PharmaTech (Cayman) Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 14)
- Wider-than-Expected Loss at ChemoCentryxZacks(Tue, May 14)
- WuXi PharmaTech Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Tue, May 14)
- WuXi AppTec Co., Ltd. Earnings Call scheduled for 8:00 am ET todayCCBN(Tue, May 14)
- /C O R R E C T I O N -- WuXi PharmaTech (Cayman) Inc./PR Newswire(Mon, May 13)
- Q1 2013 WuXi AppTec Co., Ltd. Earnings Release - After Market CloseCCBN(Mon, May 13)
- Wuxi Pharmatech Earnings Preview: Can This Streak Continue?at Wall St. Cheat Sheet(Sat, May 11)
- Dendreon Narrows 1Q LossZacks(Fri, May 10)
- Good News for Cubist PharmaceuticalsZacks(Thu, May 9)
- Narrower-than-Expected Loss at ArQuleZacks(Thu, May 9)
- Wider-than-Expected Loss at CorceptZacks(Tue, May 7)
- Valeant Misses Earnings and Revenue Estimate in 1Q (Revised)Zacks(Tue, May 7)
- China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Millionat Seeking Alpha(Sun, May 5)
Key Statistics
| Forward P/E (1 yr): | 12.16 |
|---|
| P/S (ttm): | 2.86 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.51 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.39 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | 1.14 |
|---|
Business Summary
Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in China and the United States.
View More